NCT05265247View on ClinicalTrials.gov

Bioequivalence Study of Esomeprazole 20 Milligram (mg) Delayed-Release Capsules in Healthy Adult Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

61

Participants

Timeline

Start Date

March 2, 2022

Primary Completion Date

June 2, 2022

Study Completion Date

June 2, 2022

Conditions
Gastrointestinal Diseases
Interventions
DRUG

Esomeprazole 20 mg Delayed-Release Capsules

Esomeprazole 20 mg delayed-release capsules will be given as one capsule once daily as oral administration.

DRUG

Esomeprazole 20 mg Delayed-Release Capsules (Nexium 24HR)

Esomeprazole 20 mg delayed-release capsules (Nexium 24HR) will be given as one capsule once daily as oral administration.

Trial Locations (1)

G1P0A2

Syneos health, Québec

All Listed Sponsors
lead

HALEON

INDUSTRY